Heidi C. Lew, PharmD
Articles
September 16th 2013
Adherence, Persistence, and Switching Patterns of Dabigatran Etexilate
Kimberly Tsai, PharmD Sara C. Erickson, PharmD Jianing Yang, MS Ann S. M. Harada, PhD, MPH Brian K. Solow, MD Heidi C. Lew, PharmD
We present a descriptive analysis utilizing pharmacy claims from a managed care population to quantify adherence, persistence, and switching patterns for patients initiating dabigatran.
February 5th 2010
Improving Patient Self-Management of Multiple Sclerosis Through a Disease Therapy Management Program
Karen M. Stockl, PharmD Jennifer S. Shin, PharmD Sherry Gong, MS Ann S. M. Harada, PhD, MPH Brian K. Solow, MD Heidi C. Lew, PharmD
This study evaluated the effect of a multiple sclerosis disease therapy management program on medication adherence, therapy persistence, relapses, work productivity, and quality of life.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: September 19th 2024 | Updated: November 21st 2024
Institute for Value-Based Medicine®: Speakers Use AML Studies to Illustrate Effects of Disparities, Neighborhood Stress on Outcomes
